India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key Players, Regulatory Perspective, Margins and Revenue Contribution)
Executive Summary
The Indian neuropsychiatry market is driven by the consumer awareness of health care resulting in access for early treatment along with increasing cases of mental disorders.
Indian Neuropsychiatry Market is a growing market with key players holding dominant positions. The report is classified on the basis of drugs market as well as the devices market. Indian Neuropsychiatry Drugs Market has been growing at an average pace over the last five years on account of rising healthcare expenditure, increasing diagnostic cases of epilepsy and other divisions of neurology. During 2015-20, Indian Neuropsychiatry Drugs Market is anticipated to grow at an increased rate on account of higher cases of Alzheimer patients especially in India. Moreover, consumers are increasingly becoming aware of the healthcare leading to large number of neurology treatments being performed.
The neuropsychiatry devices market is still on the growing path at a CAGR of 9.16% valued at xx million USD by 2020 from xx million USD in 2015 where both domestic and international players are having strong presence in diagnostic and treatment devices, considering more number of patients are being diagnosed using the devices. Also, when the patients are unresponsive to the medicinal drugs, treatment devices are used as a next step of measurement. Due to the fast paced lifestyle of population, increasing number of patients are suffering from neurological disorders and are opting for early treatment, thereby, driving the neuropsychiatric market in India.
According to Azoth Analytics research report, “Indian Neuropsychiatry Market (2015-2020F)” Indian Neuropsychiatry Market is projected to exhibit a CAGR of 9.12% during 2015 - 2020. Few of the leading companies operating in neuropsychiatric drug market in India include Sun Pharma, Intas, Torrent, Sanofi & Abbott whereas companies in devices market in India include RMS India, Nihon Kohden etc.
Scope of the Report
India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key Players, Regulatory Perspective, Margins and Revenue Contribution) analyses the following aspects of Indian Neuropsychiatry Drugs and Devices Market:
The Indian neuropsychiatry market is driven by the consumer awareness of health care resulting in access for early treatment along with increasing cases of mental disorders.
Indian Neuropsychiatry Market is a growing market with key players holding dominant positions. The report is classified on the basis of drugs market as well as the devices market. Indian Neuropsychiatry Drugs Market has been growing at an average pace over the last five years on account of rising healthcare expenditure, increasing diagnostic cases of epilepsy and other divisions of neurology. During 2015-20, Indian Neuropsychiatry Drugs Market is anticipated to grow at an increased rate on account of higher cases of Alzheimer patients especially in India. Moreover, consumers are increasingly becoming aware of the healthcare leading to large number of neurology treatments being performed.
The neuropsychiatry devices market is still on the growing path at a CAGR of 9.16% valued at xx million USD by 2020 from xx million USD in 2015 where both domestic and international players are having strong presence in diagnostic and treatment devices, considering more number of patients are being diagnosed using the devices. Also, when the patients are unresponsive to the medicinal drugs, treatment devices are used as a next step of measurement. Due to the fast paced lifestyle of population, increasing number of patients are suffering from neurological disorders and are opting for early treatment, thereby, driving the neuropsychiatric market in India.
According to Azoth Analytics research report, “Indian Neuropsychiatry Market (2015-2020F)” Indian Neuropsychiatry Market is projected to exhibit a CAGR of 9.12% during 2015 - 2020. Few of the leading companies operating in neuropsychiatric drug market in India include Sun Pharma, Intas, Torrent, Sanofi & Abbott whereas companies in devices market in India include RMS India, Nihon Kohden etc.
Scope of the Report
India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key Players, Regulatory Perspective, Margins and Revenue Contribution) analyses the following aspects of Indian Neuropsychiatry Drugs and Devices Market:
- Product Overview (Top Companies Market).
- Market, Drivers & Challenges and Trends.
- Indian Neuropsychiatry Drugs Market, Size & Forecast.
- Indian Neuropsychiatry Devices Market, Size & Forecast.
- To gain an in-depth understanding of Indian neuropsychiatry market
- To identify the on-going trends and anticipated growth in the next five years
- To help industry consultants, neuropsychiatric drugs and devices manufacturers, suppliers and distributors align their market-centric strategies
- To gain insights on the prevalent market entry strategies in neuropsychiatric market for domestic as well as foreign companies
- To obtain research based business decision and add weight to presentations and marketing material
- To gain competitive knowledge of leading players
- To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer’s specific needs
1. RESEARCH METHODOLOGY
2. PRODUCT OVERVIEW
3. EXECUTIVE SUMMARY
4. INDIA ECONOMIC PROFILE
5. PRODUCT OVERVIEW
6. INDIA NEUROPSYCHIATRY INDUSTRY STRUCTURE
7. NEUROPSYCHIATRY OUTLOOK IN INDIA
8. INDIA NEUROPSYCHIATRY MARKET OUTLOOK
8.1. India Neuropsychiatry -Treatment Devices Market Size & Forecast
8.1.1. By Value (Historic 2010-14)
8.1.2. By Value (Forecast 2015E-2020F)
8.1.3. By Drugs, By Value, By Percentage (Estimated 2015E)
8.1.4. By Drugs, By Value, By Percentage (Forecast 2020F)
8.2. India Neuropsychiatry - Total Devices Market Size & Forecast
8.2.1. By Value (Historic 2010-14)
8.2.2. By Value (Forecast 2015E-2020F)
8.2.3. By Region (Estimated 2015E)
8.2.4. By Region (Forecast 2020F)
8.3. India Neuropsychiatry -Treatment Devices Market Size & Forecast
8.3.1. By Value (Estimated 2015E)
8.3.2. By Value (Forecast 2020F)
8.4. India Neuropsychiatry -Treatment Devices Market Size & Forecast
8.4.1. By Value (Estimated 2015E)
8.4.2. By Value (Forecast 2020F)
8.5. India Neuropsychiatry Market-Drugs Market Size & Forecast
8.5.1. By Value (Historic 2010-14)
8.5.2. By Value (Forecast 2015E-2020F)
8.5.3. By Region (Estimated 2015E)
8.5.4. By Region (Forecast 2020F)
9. INDIA NEUROPSYCHIATRY MARKET-POLICY AND REGULATORY LANDSCAPE
10. INDIA NEUROPSYCHIATRY MARKET- DYNAMICS
10.1. Drivers
10.2. Challenges
11. INDIA NEUROPSYCHIATRY INDUSTRY-TRENDS & DEVELOPMENTS
12. INDIA ECONOMIC PROFILE
13. NEUROPSYCHIATRY INDUSTRY SWOT ANALYSIS
14. MARKET ENTRY STRATEGIES FOR FOREIGN COMPANIES
15. INDIA NEUROPSYCHIATRY DRUG MARKET ANALYSIS, BY MAJOR DRUG MANUFACTURERS
16. COMPETITIVE LANDSCAPE
17. COMPANY PROFILING
17.1. Sun Pharmaceutical Industries Ltd.
17.2. Torrent Pharma
17.3. GlaxoSmithKline Pharmaceuticals Ltd.
17.4. Cipla
17.5. Abbott Limited
17.6. Biocon Limited
17.7. Glenmark Pharmaceuticals
17.8. Alembic Ltd.
17.9. Nicholas Primal
17.10. Aventis Pharma Limited
18. STRATEGIC RECOMMENDATIONS
2. PRODUCT OVERVIEW
3. EXECUTIVE SUMMARY
4. INDIA ECONOMIC PROFILE
5. PRODUCT OVERVIEW
6. INDIA NEUROPSYCHIATRY INDUSTRY STRUCTURE
7. NEUROPSYCHIATRY OUTLOOK IN INDIA
8. INDIA NEUROPSYCHIATRY MARKET OUTLOOK
8.1. India Neuropsychiatry -Treatment Devices Market Size & Forecast
8.1.1. By Value (Historic 2010-14)
8.1.2. By Value (Forecast 2015E-2020F)
8.1.3. By Drugs, By Value, By Percentage (Estimated 2015E)
8.1.4. By Drugs, By Value, By Percentage (Forecast 2020F)
8.2. India Neuropsychiatry - Total Devices Market Size & Forecast
8.2.1. By Value (Historic 2010-14)
8.2.2. By Value (Forecast 2015E-2020F)
8.2.3. By Region (Estimated 2015E)
8.2.4. By Region (Forecast 2020F)
8.3. India Neuropsychiatry -Treatment Devices Market Size & Forecast
8.3.1. By Value (Estimated 2015E)
8.3.2. By Value (Forecast 2020F)
8.4. India Neuropsychiatry -Treatment Devices Market Size & Forecast
8.4.1. By Value (Estimated 2015E)
8.4.2. By Value (Forecast 2020F)
8.5. India Neuropsychiatry Market-Drugs Market Size & Forecast
8.5.1. By Value (Historic 2010-14)
8.5.2. By Value (Forecast 2015E-2020F)
8.5.3. By Region (Estimated 2015E)
8.5.4. By Region (Forecast 2020F)
9. INDIA NEUROPSYCHIATRY MARKET-POLICY AND REGULATORY LANDSCAPE
10. INDIA NEUROPSYCHIATRY MARKET- DYNAMICS
10.1. Drivers
10.2. Challenges
11. INDIA NEUROPSYCHIATRY INDUSTRY-TRENDS & DEVELOPMENTS
12. INDIA ECONOMIC PROFILE
13. NEUROPSYCHIATRY INDUSTRY SWOT ANALYSIS
14. MARKET ENTRY STRATEGIES FOR FOREIGN COMPANIES
15. INDIA NEUROPSYCHIATRY DRUG MARKET ANALYSIS, BY MAJOR DRUG MANUFACTURERS
16. COMPETITIVE LANDSCAPE
17. COMPANY PROFILING
17.1. Sun Pharmaceutical Industries Ltd.
17.2. Torrent Pharma
17.3. GlaxoSmithKline Pharmaceuticals Ltd.
17.4. Cipla
17.5. Abbott Limited
17.6. Biocon Limited
17.7. Glenmark Pharmaceuticals
17.8. Alembic Ltd.
17.9. Nicholas Primal
17.10. Aventis Pharma Limited
18. STRATEGIC RECOMMENDATIONS
LIST OF FIGURES
Figure 1: Neuropsychiatry Devices and their Classification
Figure 2: Indian Neuropsychiatry Devices Industry Structure
Figure 3: India Healthcare Market, By Type of service offered and sector, 2014
Figure 4: India Health Care Delivery System
Figure 5: India Drug Industry Value Chain, By Type of service offered and sector, 2014
Figure 6: Neuropsychiatric Market Value in India, 2010-2014 (in USD Billion)
Figure 7: Healthcare Expenditure Total Percentage of GDP in India (in %)
Figure 8: Per Capita Healthcare Expenditure in India (in USD)
Figure 9: Urban Population in India (in %)
Figure 10: Neuropsychiatric Market Value in India, 2015E-2020F (in USD Billion/INR)
Figure 11: Neuropsychiatric Market Value in India, By Drug and Devices, By Percentage, 2015E
Figure 12: Neuropsychiatric Market Value in India, By Drug and Devices, By Percentage, 2020F
Figure 13: Total Neuropsychiatric Devices Market Value in India, 2010-2014 (in USD Million/INR Thousand Crore)
Figure 14: Total Neuropsychiatric Devices Market Value in India, 2015E-2020F (in USD Million/INR Thousand Crore)
Figure 15: Neuropsychiatric Devices Market Value in India, By Region, 2015E
Figure 16: Neuropsychiatric Devices Market Value in India, By, Region 2020F
Figure 17: Neuropsychiatric Device Market Value in India, By Diagnostics and Treatment - 2015E
Figure 18: Neuropsychiatric Device Market Value in India, By Diagnostics and Treatment- 2020F
Figure 19: India Neuropsychiatry Drug Market Size , By Value, 2010-2014(USD Billion/INR Thousand Crore)
Figure 20: India Neuropsychiatry Drug Market Size , By Value, 2015E-2020F(USD Billion/INR Thousand Crore)
Figure 21: Neuropsychiatric Drugs Market Value in India, By Region 2015E
Figure 22: Neuropsychiatric Drugs Market Value in India, By Region 2020F
Figure 23: Sales Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 24: EBITDA Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 25: EBIT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 26: PBT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 27: PAT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 28: Current Ratio Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 29: Gross Profit Ratio Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 30: Debt Equity Ratio Comparison of Large Size Neuropsychiatric Market Players , 2011-2015 (INR Crores)
Figure 31: Sales Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 32: EBITDA Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 33: EBIT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 34: PBT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 35: PAT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 36: Current Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 37: Gross Profit Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 38: Debt Equity Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 39: Alembic Ltd. Percentage Revenue, By Business Segment (2014 E)
Figure 40: Nicholas Piramal Percentage Revenue, By Business Segment (2015)
Figure 41: Nicholas Piramal Percentage Revenue, By Geography (2015)
Figure 1: Neuropsychiatry Devices and their Classification
Figure 2: Indian Neuropsychiatry Devices Industry Structure
Figure 3: India Healthcare Market, By Type of service offered and sector, 2014
Figure 4: India Health Care Delivery System
Figure 5: India Drug Industry Value Chain, By Type of service offered and sector, 2014
Figure 6: Neuropsychiatric Market Value in India, 2010-2014 (in USD Billion)
Figure 7: Healthcare Expenditure Total Percentage of GDP in India (in %)
Figure 8: Per Capita Healthcare Expenditure in India (in USD)
Figure 9: Urban Population in India (in %)
Figure 10: Neuropsychiatric Market Value in India, 2015E-2020F (in USD Billion/INR)
Figure 11: Neuropsychiatric Market Value in India, By Drug and Devices, By Percentage, 2015E
Figure 12: Neuropsychiatric Market Value in India, By Drug and Devices, By Percentage, 2020F
Figure 13: Total Neuropsychiatric Devices Market Value in India, 2010-2014 (in USD Million/INR Thousand Crore)
Figure 14: Total Neuropsychiatric Devices Market Value in India, 2015E-2020F (in USD Million/INR Thousand Crore)
Figure 15: Neuropsychiatric Devices Market Value in India, By Region, 2015E
Figure 16: Neuropsychiatric Devices Market Value in India, By, Region 2020F
Figure 17: Neuropsychiatric Device Market Value in India, By Diagnostics and Treatment - 2015E
Figure 18: Neuropsychiatric Device Market Value in India, By Diagnostics and Treatment- 2020F
Figure 19: India Neuropsychiatry Drug Market Size , By Value, 2010-2014(USD Billion/INR Thousand Crore)
Figure 20: India Neuropsychiatry Drug Market Size , By Value, 2015E-2020F(USD Billion/INR Thousand Crore)
Figure 21: Neuropsychiatric Drugs Market Value in India, By Region 2015E
Figure 22: Neuropsychiatric Drugs Market Value in India, By Region 2020F
Figure 23: Sales Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 24: EBITDA Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 25: EBIT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 26: PBT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 27: PAT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 28: Current Ratio Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 29: Gross Profit Ratio Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 30: Debt Equity Ratio Comparison of Large Size Neuropsychiatric Market Players , 2011-2015 (INR Crores)
Figure 31: Sales Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 32: EBITDA Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 33: EBIT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 34: PBT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 35: PAT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 36: Current Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 37: Gross Profit Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 38: Debt Equity Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 39: Alembic Ltd. Percentage Revenue, By Business Segment (2014 E)
Figure 40: Nicholas Piramal Percentage Revenue, By Business Segment (2015)
Figure 41: Nicholas Piramal Percentage Revenue, By Geography (2015)
LIST OF TABLES
Table 1: Mental Patients Statistics in India, 2012
Table 2: Patients admitted to the Long term Mental Medical care in India, 2012
Table 3: Number of Patients with Mental Disorders, By state, 2013
Table 1: Mental Patients Statistics in India, 2012
Table 2: Patients admitted to the Long term Mental Medical care in India, 2012
Table 3: Number of Patients with Mental Disorders, By state, 2013
